J Constantinidis. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Amines/metabolismButyrophenones/therapeutic useChorea/chemically inducedChorea/metabolismDiazepam/therapeutic useDihydroxyphenylalanine/adverse effectsDopamine/metabolismGanglia/physiopathologyGlobus Pallidus/metabolismHomovanillic Acid/metabolismHumansHuntington Disease/drug therapyHuntington Disease/metabolismMental Disorders/drug therapyMethyldopa/therapeutic useMethyltyrosines/therapeutic useModels, NeurologicalMovement Disorders/chemically inducedMovement Disorders/physiopathologyPhenothiazines/therapeutic usePhysostigmine/therapeutic useReserpine/therapeutic useThalamus/metabolismTranquilizing Agents/adverse effectsTranquilizing Agents/therapeutic useTyrosine/adverse effects
Substances: See more » AminesButyrophenonesMethyltyrosinesPhenothiazinesTranquilizing AgentsTyrosineMethyldopaDihydroxyphenylalanineReserpinePhysostigmineDiazepamDopamineHomovanillic Acid
Year: 1972 PMID: 4272133
Source DB: PubMed Journal: Rev Neurol (Paris) ISSN: 0035-3787 Impact factor: 2.607